A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Louis P GarrisonMilton C Weinstein

Abstract

This summary section first lists key points from each of the six sections of the report, followed by six key recommendations. The Special Task Force chose to take a health economics approach to the question of whether a health plan should cover and reimburse a specific technology, beginning with the view that the conventional cost-per-quality-adjusted life-year metric has both strengths as a starting point and recognized limitations. This report calls for the development of a more comprehensive economic evaluation that could include novel elements of value (e.g., insurance value and equity) as part of either an "augmented" cost-effectiveness analysis or a multicriteria decision analysis. Given an aggregation of elements to a measure of value, consistent use of a cost-effectiveness threshold can help ensure the maximization of health gain and well-being for a given budget. These decisions can benefit from the use of deliberative processes. The six recommendations are to: 1) be explicit about decision context and perspective in value assessment frameworks; 2) base health plan coverage and reimbursement decisions on an evaluation of the incremental costs and benefits of health care technologies as is provided by cost-effectiveness...Continue Reading

Citations

Mar 21, 2018·PharmacoEconomics Open·Paula K Lorgelly
Sep 25, 2018·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Peter J NeumannGillian D Sanders
Feb 21, 2019·Journal of Managed Care & Specialty Pharmacy·Louis P GarrisonMike Kenston
Jun 4, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan D Campbell, Melanie D Whittington
Sep 19, 2019·International Journal of Technology Assessment in Health Care·Neill Booth
Sep 5, 2019·Journal for Immunotherapy of Cancer·Peter Paul YuLouis P Garrison
Dec 6, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melanie D WhittingtonJonathan D Campbell
May 30, 2020·Journal of Evidence-based Medicine·Lorcan Clarke
Jul 3, 2019·Health and Quality of Life Outcomes·Fabia GansenWolf Rogowski
Jul 18, 2020·The Patient·Susan dosReisJulia F Slejko
Aug 29, 2020·Journal of Managed Care & Specialty Pharmacy·Praveen ThokalaMike Drummond
May 26, 2018·JAMA : the Journal of the American Medical Association·Peter J Neumann, Joshua T Cohen
Mar 7, 2020·Forum for Health Economics & Policy·David L VeenstraScott D Ramsey
Sep 6, 2018·PharmacoEconomics Open·Vakaramoko DiabyAlberto J Montero
May 19, 2019·Journal for Immunotherapy of Cancer·Howard L KaufmanWendy K D Selig
Aug 15, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Doug CoyleKoonal Shah
Oct 4, 2019·Therapeutic Advances in Gastroenterology·Amir ShlomaiDaniel A Goldstein
Dec 4, 2019·PharmacoEconomics·T Joseph MattinglyC Daniel Mullins
Apr 1, 2020·Journal of Managed Care & Specialty Pharmacy·John B Watkins, Emily G Tsiao
Nov 30, 2019·Journal of Managed Care & Specialty Pharmacy·Andrew P BroganAllan Coukell
Apr 18, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael DrummondRosanna Tarricone
Apr 1, 2020·Journal of Managed Care & Specialty Pharmacy·Louis P GarrisonAdrian Towse
May 1, 2019·Journal of Managed Care & Specialty Pharmacy·Jeroen P JansenJeffrey R Curtis
Aug 7, 2018·Health Affairs·Jonathan D CampbellAndrew H Briggs
Sep 27, 2019·Journal of Managed Care & Specialty Pharmacy·Louis P Garrison, Adrian Towse
Sep 17, 2020·Clinical Pharmacology and Therapeutics·Daniel Hill-McManusDyfrig A Hughes
Nov 30, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Josh J CarlsonR Brett McQueen
Oct 23, 2020·European Journal of Human Genetics : EJHG·Shantel E WalcottRobin Z Hayeems
Feb 2, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Darius N Lakdawalla, Charles E Phelps
Mar 3, 2021·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Richard SawatzkyUNKNOWN Response Shift – in Sync Working Group
Mar 3, 2021·Cost Effectiveness and Resource Allocation : C/E·Bernarda ZamoraAdrian Towse
Mar 11, 2021·Journal of Medical Ethics·Jonathan Anthony Michaels
May 12, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Logan TrenamanJeffrey S Hoch
May 3, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Adrian TowseRachel Silverman
May 15, 2021·Journal of Medical Economics·Charles MakinDana Goldman
Jun 1, 2021·Frontiers in Pharmacology·Alessandra BlondaSteven Simoens
Jun 10, 2021·Applied Health Economics and Health Policy·Patricia Cubi-MollaNancy Devlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Patricia M DanzonMark V Pauly
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Richard J WillkeScott D Ramsey
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Charles E PhelpsPatricia M Danzon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Louis P GarrisonPeter Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Darius N LakdawallaPatricia M Danzon
© 2022 Meta ULC. All rights reserved